Abstract
Objectives
Use of traditional herbal medicines especially by those affected by chronic diseases, such as diabetes mellitus is important. The objective of this study was to assess trend and Pattern of using traditional herbal medicines by diabetic population in Iran.
Methods
The results of this study are extracted from the National Stepwise approach to chronic disease risk factor surveillance (STEPs), conducted in 2005- 2016 in Iran. A total of 3095 Iranian diabetic individuals, aged more than 25 years in 2005, 1470 diabetics in 2006, 1633 diabetics in 2007, 1652 diabetics in 2008, 1563 diabetics in 2009, and 1005 diabetics in 2011 were included in this study. We couldn’t use data in 2016 because in 2016, traditional herbal use has not been questioned. First, a descriptive analysis of the study variables and prevalence of herbal use for each year, was performed. Thereafter, to determine which variables were independent predictors of adherence to herbal use, we performed multivariate logistic regression.
Results
Using traditional herbal medicines among Iranian adult population was increased from 11.1 (9.98–12.20) in 2005 to 23.5 (20.87–26.25) in 2011. The results show increase in herbal medicine use in all age groups, both urban and rural areas, and both male and female over time. Also, we found that using traditional herbal medicines was more common among female compared with male (24.2% versus 21.8%), older than middle-aged people (24.4% versus 15.9%), and people living in urban areas compared with rural area (24.13% versus 20.95%) in 2011.
Conclusion
The use of traditional herbs for treatment, alone or in combination with other therapies by the patients who have diabetes has increased over the time. Considering the high level of using traditional herbal medicines in treatment of diabetes and because of the possible herb–drug interactions, policymakers need to take appropriate interventions to control herb store and increase people's knowledge about the herbal usage.
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- CAM:
-
Complementary and alternative medicine
- IDF:
-
International Diabetes Federation
- MENA:
-
Middle Eastern and North Africa
- STEPs:
-
STEPwise approach to chronic disease risk factor surveillance
- AOR:
-
Adjusted odds ratio
- DM:
-
Diabetes Mellitus
References
Ayele AA, Tegegn HG, Haile KT, Belachew SA, Mersha AG, Erku DA. Complementary and alternative medicine use among elderly patients living with chronic diseases in a teaching hospital in Ethiopia. Complement Ther Med. 2017;35:115–9.
WHO. Noncommunicable diseases country profiles 2011; 2011.
Misganaw A, Mariam DH, Ali A, Araya T. Epidemiology of major non-communicable diseases in Ethiopia: a systematic review. J Health Popul Nutr. 2014;32(1):1.
Zokaei A, Ziapour A, Khanghahi ME, Lebni JY, Irandoost SF, Toghroli R, et al. Investigating high blood pressure, type-2 diabetes, dislipidemia, and body mass index to determine the health status of people over 30 years. J Educ Health Promot. 2020;9:333.
AsfawErku D, BasaznMekuria A. Prevalence and correlates of complementary and alternative medicine use among hypertensive patients in Gondar Town, Ethiopia. Evid Based Complement Altern Med. 2016;2016:6987636.
Hy Chang, Wallis M, Tiralongo E. Use of complementary and alternative medicine among people living with diabetes: literature review. J Adv Nurs. 2007;58(4):307–19.
Hashempur MH, Heydari M, Mosavat SH, Heydari ST, Shams M. Complementary and alternative medicine use in Iranian patients with diabetes mellitus. J Integr Med. 2015;13(5):319–25.
Canizares M, Hogg-Johnson S, Gignac MA, Glazier RH, Badley EM. Changes in the use practitioner-based complementary and alternative medicine over time in Canada: Cohort and period effects. PLoS one. 2017;12(5):e0177307.
Chang CL, Lin Y, Bartolome AP, Chen Y-C, Chiu S-C, Yang W-C. Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evid Based Complement Altern Med. 2013;2013:378657.
Wazaify M, Afifi FU, El-Khateeb M, Ajlouni K. Complementary and alternative medicine use among Jordanian patients with diabetes. Complement Ther Clin Pract. 2011;17(2):71–5.
Modak M, Dixit P, Londhe J, Ghaskadbi S, Devasagayam TPA. Recent advances in Indian herbal drug research guest editor: Thomas Paul Asir Devasagayam Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr. 2007;40(3):163–73.
Wu C-H, Wang C-C, Tsai M-T, Huang W-T, Kennedy J. Trend and pattern of herb and supplement use in the United States: results from the 2002, 2007, and 2012 national health interview surveys. Evid Based Complement Altern Med. 2014;2014:872320.
Menniti-Ippolito F, Gargiulo L, Bologna E, Forcella E, Raschetti R. Use of unconventional medicine in Italy: a nation-wide survey. Eur J Clin Pharmacol. 2002;58(1):61–4.
Brahmi SA, El M’rabet FZ, Benbrahim Z, Akesbi Y, Amine B, Nejjari C, et al. Complementary medicine use among Moroccan patients with cancer: a descriptive study. Pan Afr Med J. 2011;10:36.
Gupta M, Shafiq N, Kumari S, Pandhi P. Patterns and perceptions of complementary and alternative medicine (CAM) among leukaemia patients visiting haematology clinic of a north Indian tertiary care hospital. Pharmacoepidemiol Drug Saf. 2002;11(8):671–6.
Behnood-Rod A, Khoshkbejari MAP, Pourzargar P, Hassanzadeh M, Moharamzad Y, Foroughi F. Complementary and alternative medicine use among Iranian patients attending urban outpatient general practices. Complement Ther Clin Pract. 2018;30:58–63.
Erenguc F.N. Complementary and alternative medicine: Current trends and predicting future use. University of Florida; 2014.
Dannemann K, Hecker W, Haberland H, Herbst A, Galler A, Schäfer T, et al. Use of complementary and alternative medicine in children with type 1 diabetes mellitus–prevalence, patterns of use, and costs. Pediatr Diabetes. 2008;9(3pt1):228–35.
Tsasis P, Wu J, An A, Wong HJ, An X, Mei Z, et al. Conceptualizing type 2 diabetes and its management. J Multidiscip Healthc. 2016;9:133.
Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137–49.
Bower AM, Real Hernandez LM, Berhow MA, De Mejia EG. Bioactive compounds from culinary herbs inhibit a molecular target for type 2 diabetes management, dipeptidyl peptidase IV. J Agric Food Chem. 2014;62(26):6147–58.
Nattrass N. Who consults sangomas in Khayelitsha? An exploratory quantitative analysis. Soc Dyn. 2005;31(2):161–82.
Kashani L, Hassanzadeh E, Mirzabeighi A, Akhondzadeh S. Knowledge, attitude and practice of herbal remedies in a group of infertile couples. Acta Med Iran. 2013;51(3):189.
Goguen JM, Leiter A. Alternative therapy: the role of selected minerals, vitamins, fiber and herbs in treating hyperglycemia. In: Gerstein HC, Haynes B, editors. Evidence-based diabetes care. Hamilton: BC Decker; 2001. p. 295–322.
Shane-McWhorter L. Biological complementary therapies: a focus on botanical products in diabetes. Diabetes Spectr. 2001;14(4):199–208.
Day C. Are herbal remedies of use in diabetes? Diabet Med. 2005;22(s1):10–2.
Liu JP, Zhang M, Wang W, Grimsgaard S. Chinese herbal medicines for type 2 diabetes mellitus. Cochrane Libr. 2002;(3): CD003642.
Atlas D. International Diabetes Federation IDF Diabetes Atlas. 7th ed. Brussels: International Diabetes Federation; 2015.
Farzadfar F, Peykari N, Larijani B, Rahimzadeh S, Rezaei-Darzi E, Saeedi Moghaddam S. A comprehensive study on national and sub national trend in thyroid cancer prevalence in the iranian population, 1990–2010. Iranian Journal of Diabetes and Metabolism. 2016;15(2):91–100.
Rezaei S, Ahmadi S, Mohamadi-Bolbanabad A, Khanijahani A. Exploring socioeconomic inequalities in the use of medicinal herbs among Iranian households: evidence from a national cross-sectional survey. BMC Complement Med Ther. 2020;20(1):336.
WHO. STEPS Planning and Implementation: STEPS Instruments for NCD Risk Factors (Core and Expanded Version 1.4). World Health Organization, Geneva. 2003. Available from: www.who.int/chp/steps/manual/en/index5.html.
Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005–2011. Diabetes Res Clin Pract. 2014;103(2):319–27.
Esteghamati A, Meysamie A, Khalilzadeh O, Rashidi A, Haghazali M, Asgari F, et al. Third national Surveillance of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. BMC Public Health. 2009;9(1):167.
Farzadfar F, Danaei G, Namdaritabar H, Rajaratnam JK, Marcus JR, Khosravi A, et al. National and subnational mortality effects of metabolic risk factors and smoking in Iran: a comparative risk assessment. Popul Health Metrics. 2011;9(1):55.
Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. JAMA. 1998;280(18):1569–75.
Wu L, He Y, Jiang B, Sun D, Wang J, Liu M, et al. Trends in prevalence, awareness, treatment and control of hypertension during 2001–2010 in an urban elderly population of China. PLoS One. 2015;10(8):e0132814.
Willcox ML, Bodeker G. Traditional herbal medicines for malaria. BMJ: Br Med J. 2004;329(7475):1156.
Langlois-Klassen D, Kipp W, Jhangri GS, Rubaale T. Use of traditional herbal medicine by AIDS patients in Kabarole District, western Uganda. Am J Trop Med Hyg. 2007;77(4):757–63.
Ryan E, Pick M, Marceau C. Use of alternative medicines in diabetes mellitus. Diabet Med. 2001;18(3):242–5.
Akilen R, Pimlott Z, Tsiami A, Robinson N. The use of complementary and alternative medicine by individuals with features of metabolic syndrome. J Integr Med. 2014;12(3):171–4.
Bhalerao M, Bolshete P, Swar B, Bangera T, Kolhe V, Tambe M, et al. Use of and satisfaction with complementary and alternative medicine in four chronic diseases: a cross-sectional study from India. 2013;26(2):75–77.
Ching SM, Zakaria ZA, Paimin F, Jalalian M. Complementary alternative medicine use among patients with type 2 diabetes mellitus in the primary care setting: a cross-sectional study in Malaysia. BMC Complement Altern Med. 2013;13(1):148.
Wu C-H, Wang C-C, Kennedy J. Changes in herb and dietary supplement use in the US adult population: a comparison of the 2002 and 2007 National Health Interview Surveys. Clin Ther. 2011;33(11):1749–58.
Al Saeedi M, El Zubier A, Bahnassi A, Al Dawood K. Patterns of belief and use of traditional remedies by diabetic patients in Mecca, Saudi Arabia. 2003;9(1-2):99–107.
Acknowledgements
The study was provided ethical approval by the University of Social Welfare and Rehabilitation Sciences (IR.USWR.REC.1396.266). The authors of this paper thank the authors whose publications they cited for their contributions and Non-Communicable Diseases Research Center of Tehran University
Author information
Authors and Affiliations
Contributions
All authors participated and approved the study design. General designing of paper: HR, FF, SA, FN, HS. Designing of methods: FF, NA, MY, SA. Analysis: HR, SA, SFI, MY, NA. Result interpretation: FF, SFI, HR, FN, SA, HS. Writing primary draft: SA, HR. Manuscript revision: All. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study was provided ethical approval by the University of Social Welfare and Rehabilitation Sciences (IR.USWR.REC.1396.266).
Consent for publication
Not applicable.
Conflict of interest
The authors declared that they have no conflict of interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ahmadi, S., Rafiey, H., Sajjadi, H. et al. Trend and pattern of using herbal medicines among people who are aware of their diabetes mellitus: results from National STEPs Surveys in 2005 to 2011 in Iran. J Diabetes Metab Disord 20, 1319–1325 (2021). https://doi.org/10.1007/s40200-021-00859-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40200-021-00859-3